India, through the National Coordination Centre-Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission (IPC), participated in the global #MedSafetyWeek campaign from 3-9 November 2025. The campaign involves 130 partner organizations across 117 countries and it marks its tenth anniversary.
Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, stated that research indicates only 5–10% of suspected side effects are reported globally.
The campaign's core message is “Everyone has a role to play in medicines safety. By reporting suspected side effects, you and I can help make medicines safer for everyone.”
The initiative aims to raise awareness among patients, families, and healthcare professionals about the importance of reporting suspected side effects of medicines.
Dr. Jai Prakash, Senior Principal Scientific Officer & Officer-in-Charge, NCC-PvPI, IPC has stated that it is not only doctors, pharmacists, or regulators and everyone has a role to play in reporting suspected side effects.
The #MedSafetyWeek campaign, which was first launched in 2016, seeks to educate the public on why, how, and where to report suspected side effects.
Key Entities Referenced
#MedSafetyWeek: A global campaign to promote the safe use of medicines by raising awareness about reporting suspected side effects.
Pharmacovigilance Programme of India (NCC-PvPI): A program participating in the #MedSafetyWeek campaign and is involved in enhancing awareness and encouraging reporting of side effects in India.
Indian Pharmacopoeia Commission (IPC): Participated in the #MedSafetyWeek campaign
Ministry of Health and Family Welfare: The ministry under which the event is organised.
Ministry of Health and Family Welfare
India Joins Global #MedSafetyWeek Campaign
to Promote Safe Use of Medicines
India Reiterates Commitment to Patient Safety through
Global #MedSafetyWeek 2025 Campaign
#MedSafetyWeek 2025 records Global Participation Across
117 Countries and 130 Organisations
Posted On: 10 NOV 2025 5:54PM by PIB Delhi
The National Coordination Centre – Pharmacovigilance Programme of India (NCC-PvPI), Indian
Pharmacopoeia Commission (IPC), participated in the tenth edition of the global #MedSafetyWeek
campaign, held from 3-9 November 2025, along with 130 partner organisations worldwide.
Speaking at the occasion, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, stated that, the
research indicates that only 5–10% of all suspected side effects are reported globally. This means that
we only see the tip of the iceberg, and that it may take longer to identify important safety issues.
Through #MedSafetyWeek, we aim to make more people aware that their report matters.
By reporting suspected side effects, each one of us contributes to making medicines safer for
everyone. Speaking up can help protect others. It’s not only doctors, pharmacists, or regulators;
everyone has a role to play,” said Dr. Jai Prakash, Senior Principal Scientific Officer & Officer-in-
Charge, NCC-PvPI, IPC.
This year’s campaign carried the core message: “Everyone has a role to play in medicines safety.
By reporting suspected side effects, you and I can help make medicines safer for everyone.” The
initiative aimed to raise awareness among patients, families, and healthcare professionals about the
importance of reporting suspected side effects of medicines.
Throughout the campaign week, individuals and stakeholders across India actively promoted the
#MedSafetyWeek message through social media and outreach activities. NCC-PvPI’s stakeholders,
including Adverse Drug Reaction (ADR) Monitoring Centres and Market Authorization Holders, also
joined the effort to enhance awareness and encourage reporting of side effects through official
channels.
BackgroundThe #MedSafetyWeek campaign, first launched in 2016, seeks to educate the public on why, how, and
where to report suspected side effects. The 2025 edition, marking its tenth anniversary, was the largest
to date, with 130 organisations across 117 countries sharing messages in over 60 languages.
***
SR
HFW- Med Safety week/10th Nov 2025/2
(Release ID: 2188441) Visitor Counter : 343
Read this release in: Urdu , Marathi , ही